FDA hands OAI classification to Novo Nordisk’s troubled Indiana sitenews2025-10-13T15:38:49+00:00October 13th, 2025|Endpoints News|
Ypsomed spends $248M to gain its first US manufacturing site news2025-10-10T10:50:38+00:00October 10th, 2025|Endpoints News|
AstraZeneca breaks ground on Virginia plant after Trump warns drugmakers to build or face tariffsnews2025-10-09T16:30:13+00:00October 9th, 2025|Endpoints News|
Xspray gets CRL over third-party production issues; Oxford Biomedica buys site from Resilience subsidiarynews2025-10-09T13:01:01+00:00October 9th, 2025|Endpoints News|
UK drafts plans to pay up to 25% more for meds to appease drugmakersnews2025-10-08T17:10:21+00:00October 8th, 2025|Endpoints News|
Lawyers scramble on how to advise clients on Trump’s 100% pharma tariff threat news2025-10-08T16:13:10+00:00October 8th, 2025|Endpoints News|
Eli Lilly earmarks $1B to boost India manufacturing footprintnews2025-10-07T12:59:35+00:00October 7th, 2025|Endpoints News|
FDA launches pilot program to improve US generic drug manufacturingnews2025-10-06T15:43:57+00:00October 6th, 2025|Endpoints News|
Cell therapy CDMO Mytos unveils its first facility in the UK news2025-10-06T12:00:45+00:00October 6th, 2025|Endpoints News|
Cidara receives BARDA award worth up to $339M for candidate that prevents flunews2025-10-03T11:06:08+00:00October 3rd, 2025|Endpoints News|
